According to FutureWise analysis the market for minimally invasive glaucoma surgery (migs) devices in 2026 is US$ 0.76 billion, and is expected to reach US$ 1.20 billion by 2036 at a CAGR of 4.67%. Growth in the market is fueled by the rising prevalence of glaucoma, a shift toward safer, quicker surgical options, and advancements in micro-stent technologies. MIGS devices provide quicker recovery, fewer complications, and are increasingly used alongside cataract surgeries, gaining wider clinical acceptance globally.
Minimally invasive glaucoma surgery (MIGS) devices are becoming an important option for treating glaucoma patients due to their ab interno technique, which helps avoid both medication reliance and conjunctival invasion. These devices, including stents, shunts, and micro implants, are primarily used for patients with mild to moderate glaucoma.
Over time, there has been a notable shift in preference towards MIGS devices compared to traditional glaucoma surgical options, largely because they offer enhanced safety and higher success rates. The market for these devices is further driven by increasing efforts from manufacturers to develop stents specifically designed for MIGS procedures that effectively lower intraocular pressure (IOP).
Additionally, the growth of the global MIGS devices market is supported by a rise in glaucoma prevalence, an expanding geriatric population that is more susceptible to various ocular conditions, including glaucoma, and ongoing demographic changes.
FutureWise Market Research has published a report that provides an insightful analysis of Minimally Invasive Glaucoma Surgery (MIGS) Devices Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=14154&type=requestsample
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmentation:
By Product
• MIGS Stents
• MIGS Shunts
• OTHER (TRABECTOME/MICRO-IMPLANTS/MICRO-CATHETERS)
By End User
• Eye Hospitals
• Ophthalmology Clinics
• Outpatient Surgical Centers
By Target
• Trabecular Meshwork
• Suprachoroidal Space
• Others
By Surgery
• Glaucoma in Conjunction with Cataract
• Stand Alone Glaucoma

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Minimally Invasive Glaucoma Surgery (MIGS) Devices Market:
• Abbvie Inc. (Glaukos Corporation)
• Asico Llc.
• Glaukos Corporation
• Istar Medical SA
• Ivantis Inc.
• Lumenis Ltd.
• Ziemer Ophthalmic Systems Ag
• Novartis International Ag (Alcon Inc.)
• Santen Pharmaceutical Co. Ltd.
• Carl Zeiss Meditec Ag

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=14154&license=multi


**Objectives of this Study: **
1. To provide a comprehensive analysis of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market By Product, By End User, By Target, By Surgery and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: [email protected]

FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | UK: +44 0113 519 7222
Website: www.futurewiseresearch.com